Braden Michael Leonard Adverum Biotechnologies, Inc. (ADVM) insider trading activity

Braden Michael Leonard is of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 141,800 shares of ADVM, which is worth approximately $714,672. The most recent transaction as insider was on Mar 27, 2025, when has been sold 16,593 shares (Common Stock) at a price of $5.19 per share, resulting in proceeds of $86,117. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K

n/a 3M change

n/a 12M change

Total Value Held $714,672

Braden Michael Leonard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 27 2025	SELL Open market or private purchase	$86,117 $5.19 p/Share	16,593 Reduced 10.48%	141,800 Common Stock
Mar 26 2025	BUY Open market or private purchase	$102,851 $5.04 p/Share	20,407 Added 14.01%	125,207 Common Stock

Also insider at

GMTX

Gemini Therapeutics, Inc. Healthcare

> 10% Shareholder

IMRA

IMARA Inc. Healthcare

> 10% Shareholder

RVP

RETRACTABLE TECHNOLOGIES INC Healthcare

> 10% Shareholder

ASTC

ASTROTECH Corp Industrials

> 10% Shareholder

MTCR

Metacrine, Inc. Healthcare

> 10% Shareholder

STSA

Satsuma Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

CYT

Cyteir Therapeutics, Inc. Healthcare

AVRO

AVROBIO, Inc. Healthcare

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

ACRS

Aclaris Therapeutics, Inc. Healthcare

ANTX

AN2 Therapeutics, Inc. Healthcare

TLIS

Talis Biomedical Corp Healthcare

BML